FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3194113007> ?p ?o ?g. }

• W3194113007 endingPage "262" @default.
• W3194113007 startingPage "255" @default.
• W3194113007 abstract "Objective Abdominal aortic aneurysm (AAA) is a chronic inflammatory disease characterized by localized progressive dilatation. Currently, paeonol has been shown to possess anti-inflammatory and protective cardiovascular properties. Our study aimed to investigate the potential influences of paeonol on AAA progression. Methods Experimental AAAs were created in C57BL/6J mice by intra-aortic infusion of porcine pancreatic elastase, and then intragastrically administered paeonol (20 mg/kg/day) for 14 days. The effects of paeonol on experimental AAA were measured by ultrasound imaging, histopathology, and western blot analyses. Results Paeonol treatment limited the enlargement of the aneurysmal diameter and alleviated the depletion of elastic fibers and vascular smooth muscle cells (VSMCs). Furthermore, the infiltration of CD68+ macrophages and CD8+ lymphocytes was obviously attenuated after paeonol administration, along with mural neoangiogenesis. Western blot results showed that paeonol inhibited the expression of matrix metalloproteinase (MMP) and the NF-κB pathway activation. Conclusions Paeonol might prevent experimental AAA progression by inhibiting the NF-κB pathway, which suggests that it is a potential drug for AAA. Abdominal aortic aneurysm (AAA) is a chronic inflammatory disease characterized by localized progressive dilatation. Currently, paeonol has been shown to possess anti-inflammatory and protective cardiovascular properties. Our study aimed to investigate the potential influences of paeonol on AAA progression. Experimental AAAs were created in C57BL/6J mice by intra-aortic infusion of porcine pancreatic elastase, and then intragastrically administered paeonol (20 mg/kg/day) for 14 days. The effects of paeonol on experimental AAA were measured by ultrasound imaging, histopathology, and western blot analyses. Paeonol treatment limited the enlargement of the aneurysmal diameter and alleviated the depletion of elastic fibers and vascular smooth muscle cells (VSMCs). Furthermore, the infiltration of CD68+ macrophages and CD8+ lymphocytes was obviously attenuated after paeonol administration, along with mural neoangiogenesis. Western blot results showed that paeonol inhibited the expression of matrix metalloproteinase (MMP) and the NF-κB pathway activation. Paeonol might prevent experimental AAA progression by inhibiting the NF-κB pathway, which suggests that it is a potential drug for AAA." @default.
• W3194113007 created "2021-08-30" @default.
• W3194113007 creator A5000011776 @default.
• W3194113007 creator A5009099023 @default.
• W3194113007 creator A5014550035 @default.
• W3194113007 creator A5022162722 @default.
• W3194113007 creator A5028269245 @default.
• W3194113007 creator A5038282325 @default.
• W3194113007 creator A5049286118 @default.
• W3194113007 date "2021-11-01" @default.
• W3194113007 modified "2023-10-18" @default.
• W3194113007 title "Paeonol Ameliorates Abdominal Aortic Aneurysm Progression by the NF-κB Pathway" @default.
• W3194113007 cites W1991789551 @default.
• W3194113007 cites W2012847092 @default.
• W3194113007 cites W2018241482 @default.
• W3194113007 cites W2049484199 @default.
• W3194113007 cites W2064399578 @default.
• W3194113007 cites W2064711537 @default.
• W3194113007 cites W2101306706 @default.
• W3194113007 cites W2150033965 @default.
• W3194113007 cites W2152919836 @default.
• W3194113007 cites W2153688070 @default.
• W3194113007 cites W2165424886 @default.
• W3194113007 cites W2415721097 @default.
• W3194113007 cites W2478547083 @default.
• W3194113007 cites W2515697377 @default.
• W3194113007 cites W2519342050 @default.
• W3194113007 cites W2579322339 @default.
• W3194113007 cites W2580628153 @default.
• W3194113007 cites W2616746098 @default.
• W3194113007 cites W2624747153 @default.
• W3194113007 cites W2783968358 @default.
• W3194113007 cites W2811373638 @default.
• W3194113007 cites W2884931385 @default.
• W3194113007 cites W2896631467 @default.
• W3194113007 cites W2899278816 @default.
• W3194113007 cites W2899867738 @default.
• W3194113007 cites W2900490388 @default.
• W3194113007 cites W2930013387 @default.
• W3194113007 cites W2941184640 @default.
• W3194113007 cites W2964771624 @default.
• W3194113007 cites W2970942034 @default.
• W3194113007 cites W2995342757 @default.
• W3194113007 cites W2995735301 @default.
• W3194113007 cites W3001725605 @default.
• W3194113007 cites W3002536059 @default.
• W3194113007 cites W3036465386 @default.
• W3194113007 cites W3093859431 @default.
• W3194113007 cites W372859659 @default.
• W3194113007 doi "https://doi.org/10.1016/j.avsg.2021.06.003" @default.
• W3194113007 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34411666" @default.
• W3194113007 hasPublicationYear "2021" @default.
• W3194113007 type Work @default.
• W3194113007 sameAs 3194113007 @default.
• W3194113007 citedByCount "2" @default.
• W3194113007 countsByYear W31941130072023 @default.
• W3194113007 crossrefType "journal-article" @default.
• W3194113007 hasAuthorship W3194113007A5000011776 @default.
• W3194113007 hasAuthorship W3194113007A5009099023 @default.
• W3194113007 hasAuthorship W3194113007A5014550035 @default.
• W3194113007 hasAuthorship W3194113007A5022162722 @default.
• W3194113007 hasAuthorship W3194113007A5028269245 @default.
• W3194113007 hasAuthorship W3194113007A5038282325 @default.
• W3194113007 hasAuthorship W3194113007A5049286118 @default.
• W3194113007 hasConcept C104317684 @default.
• W3194113007 hasConcept C141071460 @default.
• W3194113007 hasConcept C142724271 @default.
• W3194113007 hasConcept C185592680 @default.
• W3194113007 hasConcept C204787440 @default.
• W3194113007 hasConcept C2776098176 @default.
• W3194113007 hasConcept C2776415932 @default.
• W3194113007 hasConcept C2778833331 @default.
• W3194113007 hasConcept C2779993416 @default.
• W3194113007 hasConcept C544855455 @default.
• W3194113007 hasConcept C55493867 @default.
• W3194113007 hasConcept C71924100 @default.
• W3194113007 hasConcept C98274493 @default.
• W3194113007 hasConceptScore W3194113007C104317684 @default.
• W3194113007 hasConceptScore W3194113007C141071460 @default.
• W3194113007 hasConceptScore W3194113007C142724271 @default.
• W3194113007 hasConceptScore W3194113007C185592680 @default.
• W3194113007 hasConceptScore W3194113007C204787440 @default.
• W3194113007 hasConceptScore W3194113007C2776098176 @default.
• W3194113007 hasConceptScore W3194113007C2776415932 @default.
• W3194113007 hasConceptScore W3194113007C2778833331 @default.
• W3194113007 hasConceptScore W3194113007C2779993416 @default.
• W3194113007 hasConceptScore W3194113007C544855455 @default.
• W3194113007 hasConceptScore W3194113007C55493867 @default.
• W3194113007 hasConceptScore W3194113007C71924100 @default.
• W3194113007 hasConceptScore W3194113007C98274493 @default.
• W3194113007 hasFunder F4320321001 @default.
• W3194113007 hasLocation W31941130071 @default.
• W3194113007 hasLocation W31941130072 @default.
• W3194113007 hasOpenAccess W3194113007 @default.
• W3194113007 hasPrimaryLocation W31941130071 @default.
• W3194113007 hasRelatedWork W2067894025 @default.
• W3194113007 hasRelatedWork W2137190715 @default.
• W3194113007 hasRelatedWork W2356658133 @default.

• next